Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland; Shiley Eye Institute, University of California, San Diego, La Jolla, California.
Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland; Krieger Eye Institute, Sinai Hospital of Baltimore, Baltimore, Maryland.
Ophthalmology. 2020 Jul;127(7):956-962. doi: 10.1016/j.ophtha.2020.01.042. Epub 2020 Feb 5.
To assess the diagnostic performance and generalizability of logistic regression in classifying primary vitreoretinal lymphoma (PVRL) versus uveitis from intraocular cytokine levels in a single-center retrospective cohort, comparing a logistic regression model and previously published Interleukin Score for Intraocular Lymphoma Diagnosis (ISOLD) scores against the interleukin 10 (IL-10)-to-interleukin 6 (IL-6) ratio.
Retrospective cohort study.
Patient histories, pathology reports, and intraocular cytokine levels from 2339 patient entries in the National Eye Institute Histopathology Core database.
Patient diagnoses of PVRL versus uveitis and associated aqueous or vitreous IL-6 and IL-10 levels were collected retrospectively. From these data, cytokine levels were compared between diagnoses with the Mann-Whitney U test. A logistic regression model was trained to classify PVRL versus uveitis from aqueous and vitreous IL-6 and IL-10 samples and compared with ISOLD scores and IL-10-to-IL-6 ratios.
Area under the receiver operating characteristic curve (AUC) for each classifier and sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) at the optimal cutoff (maximal Youden index) for each classifier.
Seventy-seven lymphoma patients (10 aqueous samples, 67 vitreous samples) and 84 uveitis patients (19 aqueous samples, 65 vitreous samples) treated between October 5, 1999, and September 16, 2015, were included. Interleukin 6 levels were higher and IL-10 levels were lower in uveitis patients compared with lymphoma patients (P < 0.01). For vitreous samples, the logistic regression model, ISOLD score, and IL-10-to-IL-6 ratio achieved AUCs of 98.3%, 97.7%, and 96.3%, respectively. Sensitivity, specificity, PPV, and NPV at the optimal cutoffs for each classifier were 94.2%, 96.9%, 97%, and 94% for the logistic regression model; 92.7%, 100%, 100%, and 92.9% for the ISOLD score; and 94.2%, 95.3%, 95.6%, and 93.9% for the IL-10-to-IL-6 ratio. All models achieved complete separation between uveitis and lymphoma in the aqueous data set.
The accuracy of the logistic regression model and generalizability of the ISOLD score to an independent patient cohort suggest that intraocular cytokine analysis by logistic regression may be a promising adjunct to cytopathologic analysis, the gold standard, for the early diagnosis of primary vitreoretinal lymphoma. Further validation studies are merited.
在单中心回顾性队列中,通过比较逻辑回归模型和先前发表的眼内淋巴瘤诊断的白细胞介素评分(ISOLD)评分与白细胞介素 10(IL-10)与白细胞介素 6(IL-6)比值,评估逻辑回归在分类原发性玻璃体内视网膜淋巴瘤(PVRL)与葡萄膜炎中的诊断性能和可推广性。
回顾性队列研究。
国家眼科研究所组织病理学核心数据库中 2339 例患者的病史、病理报告和眼内细胞因子水平。
回顾性收集 PVRL 与葡萄膜炎以及相关房水或玻璃体液 IL-6 和 IL-10 水平的患者诊断。通过 Mann-Whitney U 检验比较这些数据中不同诊断之间的细胞因子水平。训练逻辑回归模型,以从房水和玻璃体 IL-6 和 IL-10 样本中分类 PVRL 与葡萄膜炎,并与 ISOLD 评分和 IL-10 与 IL-6 比值进行比较。
每个分类器的受试者工作特征曲线(ROC)下面积(AUC)以及每个分类器的最佳截断值(最大约登指数)的敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV)。
纳入了 1999 年 10 月 5 日至 2015 年 9 月 16 日期间治疗的 77 例淋巴瘤患者(10 例房水样本,67 例玻璃体样本)和 84 例葡萄膜炎患者(19 例房水样本,65 例玻璃体样本)。与淋巴瘤患者相比,葡萄膜炎患者的 IL-6 水平较高,IL-10 水平较低(P<0.01)。对于玻璃体样本,逻辑回归模型、ISOLD 评分和 IL-10 与 IL-6 比值的 AUC 分别为 98.3%、97.7%和 96.3%。每个分类器最佳截断值的敏感性、特异性、PPV 和 NPV 分别为逻辑回归模型 94.2%、96.9%、97%和 94%;ISOLD 评分 92.7%、100%、100%和 92.9%;IL-10 与 IL-6 比值 94.2%、95.3%、95.6%和 93.9%。所有模型在水样数据集均实现了葡萄膜炎与淋巴瘤的完全分离。
逻辑回归模型的准确性和 ISOLD 评分在独立患者队列中的可推广性表明,逻辑回归分析眼内细胞因子可能是早期诊断原发性玻璃体内视网膜淋巴瘤的细胞病理学分析(金标准)的有前途的辅助手段。值得进一步验证研究。